When Corrine Aylward posted on Facebook that she had been diagnosed with Stage 4 colon cancer, she asked her community of ...
Natera has reported the latest data from the Phase III CALGB (Alliance)/SWOG 80702 study, indicating that Signatera, a ...
An analysis of ctDNA testing for early detection of recurrence showed that test had high sensitivity across multiple sites of ...
Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K pathway, according to results of the randomized ALASCCA study presented at ASCO ...
A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...
AMB-066 is a potential first-in-class treatment for CRC MRD ~20,000 patients diagnosed annually in U.S.; no currently ...
Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...
Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...
Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.